Prioritization and Evaluation of Depression Candidate Genes by Combining Multidimensional Data Resources

Background Large scale and individual genetic studies have suggested numerous susceptible genes for depression in the past decade without conclusive results. There is a strong need to review and integrate multi-dimensional data for follow up validation. The present study aimed to apply prioritization procedures to build-up an evidence-based candidate genes dataset for depression. Methods Depression candidate genes were collected in human and animal studies across various data resources. Each gene was scored according to its magnitude of evidence related to depression and was multiplied by a source-specific weight to form a combined score measure. All genes were evaluated through a prioritization system to obtain an optimal weight matrix to rank their relative importance with depression using the combined scores. The resulting candidate gene list for depression (DEPgenes) was further evaluated by a genome-wide association (GWA) dataset and microarray gene expression in human tissues. Results A total of 5,055 candidate genes (4,850 genes from human and 387 genes from animal studies with 182 being overlapped) were included from seven data sources. Through the prioritization procedures, we identified 169 DEPgenes, which exhibited high chance to be associated with depression in GWA dataset (Wilcoxon rank-sum test, p = 0.00005). Additionally, the DEPgenes had a higher percentage to express in human brain or nerve related tissues than non-DEPgenes, supporting the neurotransmitter and neuroplasticity theories in depression. Conclusions With comprehensive data collection and curation and an application of integrative approach, we successfully generated DEPgenes through an effective gene prioritization system. The prioritized DEPgenes are promising for future biological experiments or replication efforts to discoverthe underlying molecular mechanisms for depression.

[1]  N. Wray,et al.  Genomewide Association for Major Depressive Disorder: A possible role for the presynaptic protein Piccolo , 2008, Molecular Psychiatry.

[2]  P. Terpstra,et al.  Poor replication of candidate genes for major depressive disorder using genome-wide association data , 2011, Molecular Psychiatry.

[3]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[4]  Tadafumi Kato,et al.  Molecular genetics of bipolar disorder and depression , 2007, Psychiatry and clinical neurosciences.

[5]  H. Nurnberg,et al.  Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors. , 1999, The Journal of clinical psychiatry.

[6]  Peilin Jia,et al.  A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case , 2009, Bioinform..

[7]  A. Serretti,et al.  Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder , 2010, Molecular Psychiatry.

[8]  A. Janssens,et al.  Meta-analyses of genetic studies on major depressive disorder , 2008, Molecular Psychiatry.

[9]  Eric J. Nestler,et al.  The molecular neurobiology of depression , 2008, Nature.

[10]  W. Rief,et al.  Depression, cytokines and experimental pain: evidence for sex-related association patterns. , 2011, Journal of affective disorders.

[11]  P. Muglia,et al.  Genome-wide association study of recurrent major depressive disorder in two European case–control cohorts , 2010, Molecular Psychiatry.

[12]  I. Levav,et al.  Lifetime and 12-month prevalence of DSM-III-R disorders in the Chile psychiatric prevalence study. , 2006, The American journal of psychiatry.

[13]  Alan R. Powell,et al.  Integration of text- and data-mining using ontologies successfully selects disease gene candidates , 2005, Nucleic acids research.

[14]  R. Bijl,et al.  Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS) , 1998, Social Psychiatry and Psychiatric Epidemiology.

[15]  N. Barden,et al.  Gene interactions in depression: pathways out of darkness. , 2007, Trends in genetics : TIG.

[16]  A. Akdoğan,et al.  Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level , 2012, Rheumatology International.

[17]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[18]  R. Hashimoto,et al.  A missense polymorphism (S205L) of the low‐affinity neurotrophin receptor p75NTR gene is associated with depressive disorder and attempted suicide , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[19]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[20]  Susumu Goto,et al.  KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..

[21]  Peilin Jia,et al.  Schizophrenia Gene Networks and Pathways and Their Applications for Novel Candidate Gene Selection , 2010, PloS one.

[22]  Kerang Zhang,et al.  Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population , 2010, Journal of Neural Transmission.

[23]  J. Cubells,et al.  Human genetics of plasma dopamine β-hydroxylase activity: applications to research in psychiatry and neurology , 2004, Psychopharmacology.

[24]  E. Snyder,et al.  The human obesity gene map: the 2001 update. , 2002, Obesity research.

[25]  M. Keshavan,et al.  Pituitary Volume in Treatment-Naïve Pediatric Major Depressive Disorder , 2006, Biological Psychiatry.

[26]  G. Abecasis,et al.  Genome-wide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. , 2004, Human molecular genetics.

[27]  J. Potash,et al.  Novel loci for major depression identified by genome-wide association study of STAR*D and meta-analysis of three studies , 2009, Molecular Psychiatry.

[28]  Á. Díaz,et al.  Gene expression patterns in brain cortex of three different animal models of depression , 2008, Genes, brain, and behavior.

[29]  R. Jope,et al.  Mood stabilizers, glycogen synthase kinase-3β and cell survival , 2002, Molecular Psychiatry.

[30]  H. Anisman,et al.  Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAA Receptor Subunits in Frontal Cortical Brain Region , 2004, The Journal of Neuroscience.

[31]  A. Meyer-Lindenberg,et al.  5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression , 2005, Nature Neuroscience.

[32]  Claude Bouchard,et al.  The Human Obesity Gene Map: The 2005 Update , 2006, Obesity.

[33]  N. Wray,et al.  Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned , 2010, Molecular Psychiatry.

[34]  Li Wang,et al.  CGI: a new approach for prioritizing genes by combining gene expression and protein-protein interaction data , 2007, Bioinform..

[35]  Sam Richman,et al.  An online database for brain disease research , 2006, BMC Genomics.

[36]  M. Goodell,et al.  Genome-wide association study of recurrent early-onset major depressive disorder , 2010, Molecular Psychiatry.

[37]  D. Levinson.  The Genetics of Depression: A Review , 2006, Biological Psychiatry.

[38]  An-Yuan Guo,et al.  ERGR: An ethanol-related gene resource , 2008, Nucleic Acids Res..

[39]  Nicholas G Martin,et al.  Genome-wide linkage analysis of multiple measures of neuroticism of 2 large cohorts from Australia and the Netherlands. , 2008, Archives of general psychiatry.

[40]  J. Gault,et al.  Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. , 2002, Archives of general psychiatry.

[41]  P. Sullivan,et al.  Genetic epidemiology of major depression: review and meta-analysis. , 2000, The American journal of psychiatry.

[42]  J. Schildkraut,et al.  The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.

[43]  Bing Zhang,et al.  WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..

[44]  F. Terry.  Human obesity. , 1987, Annals of the New York Academy of Sciences.

[45]  S. Bates,et al.  Expression Profiling of a Genetic Animal Model of Depression Reveals Novel Molecular Pathways Underlying Depressive-Like Behaviours , 2010, PloS one.

[46]  P. Joyce,et al.  A polymorphism in the dopamine β-hydroxylase gene is associated with “paranoid ideation” in patients with major depression , 2002, Biological Psychiatry.

[47]  K. Kendler,et al.  A genome‐wide linkage analysis for the personality trait neuroticism in the Irish affected sib‐pair study of alcohol dependence , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[48]  R. Duman,et al.  Antidepressant actions of the exercise-regulated gene VGF , 2007, Nature Medicine.